117 related articles for article (PubMed ID: 10564583)
1. Detection of a putative HLA-A*31012 processed (intronless) pseudogene in a laryngeal squamous cell carcinoma.
Feenstra M; Bakema J; Verdaasdonk M; Rozemuller E; van den Tweel J; Slootweg P; de Weger R; Tilanus M
Genes Chromosomes Cancer; 2000 Jan; 27(1):26-34. PubMed ID: 10564583
[TBL] [Abstract][Full Text] [Related]
2. HLA class I expression and chromosomal deletions at 6p and 15q in head and neck squamous cell carcinomas.
Feenstra M; Veltkamp M; van Kuik J; Wiertsema S; Slootweg P; van den Tweel J; de Weger R; Tilanus M
Tissue Antigens; 1999 Sep; 54(3):235-45. PubMed ID: 10519360
[TBL] [Abstract][Full Text] [Related]
3. Mutation in the beta 2m gene is not a frequent event in head and neck squamous cell carcinomas.
Feenstra M; Rozemuller E; Duran K; Stuy I; van den Tweel J; Slootweg P; de Weger R; Tilanus M
Hum Immunol; 1999 Aug; 60(8):697-706. PubMed ID: 10439315
[TBL] [Abstract][Full Text] [Related]
4. Investigation of HLA class I downregulation in breast cancer by RT-PCR.
Palmisano GL; Pistillo MP; Capanni P; Pera C; Nicolò G; Salvi S; Perdelli L; Pasciucco G; Ferrara GB
Hum Immunol; 2001 Feb; 62(2):133-9. PubMed ID: 11182222
[TBL] [Abstract][Full Text] [Related]
5. Sequence-based typing of the HLA-A10/A19 group and confirmation of a pseudogene coamplified with A*3401.
Swelsen WT; Voorter CE; van den Berg-Loonen EM
Hum Immunol; 2005 May; 66(5):535-42. PubMed ID: 15935891
[TBL] [Abstract][Full Text] [Related]
6. An immunohistochemical study of altered immunomodulatory molecule expression in head and neck squamous cell carcinoma.
Vora AR; Rodgers S; Parker AJ; Start R; Rees RC; Murray AK
Br J Cancer; 1997; 76(7):836-44. PubMed ID: 9328140
[TBL] [Abstract][Full Text] [Related]
7. Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer.
Korkolopoulou P; Kaklamanis L; Pezzella F; Harris AL; Gatter KC
Br J Cancer; 1996 Jan; 73(2):148-53. PubMed ID: 8546899
[TBL] [Abstract][Full Text] [Related]
8. Total loss of MHC class I in colorectal tumors can be explained by two molecular pathways: beta2-microglobulin inactivation in MSI-positive tumors and LMP7/TAP2 downregulation in MSI-negative tumors.
Cabrera CM; Jiménez P; Cabrera T; Esparza C; Ruiz-Cabello F; Garrido F
Tissue Antigens; 2003 Mar; 61(3):211-9. PubMed ID: 12694570
[TBL] [Abstract][Full Text] [Related]
9. Multiple mechanisms generate HLA class I altered phenotypes in laryngeal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21.
Maleno I; López-Nevot MA; Cabrera T; Salinero J; Garrido F
Cancer Immunol Immunother; 2002 Sep; 51(7):389-96. PubMed ID: 12192539
[TBL] [Abstract][Full Text] [Related]
10. Characterisation of a novel HLA-A pseudogene, HLA-BEL, with significant sequence identity with a gorilla MHC class I gene.
Williams F; Curran MD; Middleton D
Tissue Antigens; 1999 Oct; 54(4):360-9. PubMed ID: 10551419
[TBL] [Abstract][Full Text] [Related]
11. Identification of HLA a*0201 glioblastoma multiforme cell lines for immunotherapy by PCR-SSP and DNA sequencing.
Wu AH; Hall WA; Low WC
J Neurooncol; 2004 Jan; 66(1-2):1-8. PubMed ID: 15015764
[TBL] [Abstract][Full Text] [Related]
12. Complete sequencing of the HLA-A*68020102 novel allele identified in two Caucasoid families.
Longhi E; Frison S; Andreini E; Haworth S; Malagoli A; Carella G; Crespiatico L; Poli F; Scalamogna M
Hum Immunol; 2007 Mar; 68(3):206-10. PubMed ID: 17349876
[TBL] [Abstract][Full Text] [Related]
13. HLA class I antigen and transporter associated with antigen processing downregulation in metastatic lesions of head and neck squamous cell carcinoma as a marker of poor prognosis.
Bandoh N; Ogino T; Katayama A; Takahara M; Katada A; Hayashi T; Harabuchi Y
Oncol Rep; 2010 Apr; 23(4):933-9. PubMed ID: 20204276
[TBL] [Abstract][Full Text] [Related]
14. Impaired expression of proteasome subunits and human leukocyte antigens class I in human colon cancer cells.
Miyagi T; Tatsumi T; Takehara T; Kanto T; Kuzushita N; Sugimoto Y; Jinushi M; Kasahara A; Sasaki Y; Hori M; Hayashi N
J Gastroenterol Hepatol; 2003 Jan; 18(1):32-40. PubMed ID: 12519221
[TBL] [Abstract][Full Text] [Related]
15. Sequencing of HLA class I genes based on the conserved diversity of the noncoding regions: sequencing-based typing of the HLA-A gene.
Kotsch K; Wehling J; Köhler S; Blasczyk R
Tissue Antigens; 1997 Aug; 50(2):178-91. PubMed ID: 9271828
[TBL] [Abstract][Full Text] [Related]
16. An intronic mutation responsible for a low level of expression of an HLA-A*24 allele.
Laforet M; Froelich N; Parissiadis A; Bausinger H; Pfeiffer B; Tongio MM
Tissue Antigens; 1997 Oct; 50(4):340-6. PubMed ID: 9349616
[TBL] [Abstract][Full Text] [Related]
17. Multiple mechanisms underlie HLA dysregulation in cervical cancer.
Brady CS; Bartholomew JS; Burt DJ; Duggan-Keen MF; Glenville S; Telford N; Little AM; Davidson JA; Jimenez P; Ruiz-Cabello F; Garrido F; Stern PL
Tissue Antigens; 2000 May; 55(5):401-11. PubMed ID: 10885560
[TBL] [Abstract][Full Text] [Related]
18. MUTYH-associated polyposis carcinomas frequently lose HLA class I expression - a common event amongst DNA-repair-deficient colorectal cancers.
de Miranda NF; Nielsen M; Pereira D; van Puijenbroek M; Vasen HF; Hes FJ; van Wezel T; Morreau H
J Pathol; 2009 Sep; 219(1):69-76. PubMed ID: 19462419
[TBL] [Abstract][Full Text] [Related]
19. A processed HLA-A*24:02 pseudogene found in the peripheral blood of a father and his son.
Ko SY; Oh HB; Sohn YH; Jun J; Kwon OJ
Tissue Antigens; 2011 Mar; 77(3):244-6. PubMed ID: 21299531
[TBL] [Abstract][Full Text] [Related]
20. Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions.
Kageshita T; Ishihara T; Campoli M; Ferrone S
Tissue Antigens; 2005 May; 65(5):419-28. PubMed ID: 15853896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
